NCT04407494View on ClinicalTrials.gov

Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19)

CompletedOBSERVATIONAL
Enrollment

809

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

April 1, 2020

Study Completion Date

April 30, 2020

Conditions
COVID-19
Interventions
BIOLOGICAL

Reporting of anosmia, ageusia and other clinical symptoms

Reporting of anosmia, ageusia and other clinical symptoms related to COVID-19 - CODA test - SARS-CoV2 RT-PCR and ELISA

Trial Locations (1)

34295

Uhmontpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT04407494 - Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19) | Biotech Hunter | Biotech Hunter